Industry News
Colonoscopy May Reduce Advanced Cancer Risk By 70%
Mar 06, 2013
Colonoscopy screening reduces the risk of advanced colorectal cancer by about 70% in average-risk adults. The finding came from a new study led by a researcher at the Perelman School of Medicine at the University of Pennsylvania and was published in the journal Annals of Internal Medicine... Read More
Visceral Fat Causally Linked To Intestinal Cancer
Mar 06, 2013
Loss of fat by surgical removal or a calorierestricted diet reduced likelihood of developing intestinal tumors. Differences were found between male and female mice. Study emphasizes the need for strategies to reduce visceral fat... Read More
Newly Identified Biomarkers May Help Predict Progression Of Barrett's Esophagus To Esophageal Adenocarcinoma
Mar 06, 2013
Expression of most microRNAs was similar between the two conditions. A small number were differentially expressed. These microRNAs could be biomarkers for early diagnosis of progression... Read More
Many Children With Retinoblastoma May Safely Forego Adjuvant Chemotherapy
Mar 06, 2013
New results from a prospective clinical trial conducted in France show that children with low-risk retinoblastoma do not need postoperative (adjuvant) chemotherapy to prevent disease recurrence or metastasis; the results also suggest that certain patients with intermediate-risk disease can receive less aggressive adjuvant treatment, or perhaps forego it altogether... Read More
Gene Related To Obesity Increases Risk For Melanoma
Mar 05, 2013
The research shows that people with particular variations in a stretch of DNA within the FTO gene, called intron 8, could be at greater risk of developing melanoma. Variations in a different part of the FTO gene, called intron 1, are already known to be the most important genetic risk factor for obesity and overeating... Read More
Research Offers Patients Hope For New Treatments For An Aggressive And Common Lymphoma
Mar 05, 2013
The powerful master regulatory transcription factor called Bcl6 is key to the survival of a majority of aggressive lymphomas, which arise from the B-cells of the immune system. The protein has long been considered too complex to target with a drug since it is also crucial to the healthy functioning of many immune cells in the body, not just B cells gone bad... Read More
News From The Annals Of Internal Medicine: March 5, 2013
Mar 05, 2013
A special supplement on patient safety strategies will be published with the March 5 issue. In addition to the 10 articles included in the supplement, Annals of Internal Medicine also will publish a special five-page graphic narrative on the topic of medical errors. 1... Read More
With The Help Of e-Health Records, Colon Cancer Screening Doubles
Mar 05, 2013
Researchers used electronic health records to identify Group Health patients who weren't screened regularly for cancer of the colon and rectum - and to encourage them to be screened. This centralized, automated approach doubled these patients' rates of on-time screening - and saved health costs - over two years. The March 5 Annals of Internal Medicine published the randomized controlled trial... Read More
ZALTRAP® (Aflibercept) Is Now Available In The UK For The Treatment Of Advanced Metastatic Colorectal Cancer (mCRC)
Mar 05, 2013
Treatment proven to demonstrate significant survival improvement in patients with mCRC whose disease has progressed despite treatment with oxaliplatin-based regimen(2) Sanofi and Regeneron Pharmaceuticals, Inc... Read More
A Tool That Could Simply And Accurately Determine The Right Dose For Oncology
Mar 05, 2013
King Mithridates understood that poison is only as good as the dosage taken. Each day, he ingested small quantities of poison in order to become immune and escape his court's plotters. Oncologists run up against the same principle when fighting cancer. Sometimes, a small dose of chemotherapy may induce dangerous resistance mechanisms in malignant cells, resulting in relapse... Read More
Previous Page Next Page